VERWENDUNG VON LAMBDA-INTERFERONEN BEI DER BEHANDLUNG EINER MIT FETTLEIBIGKEIT IN ZUSAMMENHANG STEHENDEN STÖRUNG, VON ATHEROSKLEROSE ODER EINER GERINNUNGSSTÖRUNG

Patent europeic · EP3375452 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3375452
Numer da la dumonda
EP17161461
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
16-03-2017
Publitgà
19-09-2018
Concedì
08-01-2025
La protecziun finescha il pli tard
15-03-2037
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
A61K 38/21 (2006.01)
A61P 3/04 (2006.01)
A61P 9/10 (2006.01)
A61P 7/02 (2006.01)
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-04-2026

    Midada

    Published in Swissreg on 23.04.2026

  2. 19-11-2025

    Midada

    Published in Swissreg on 19.11.2025

  3. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  4. 07-03-2025

    Represchentant inscrit

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 07.03.2025

  5. 08-01-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 08.01.2025

Partidas

Possessur

Andreakos, Evangelos

15451 Athens, GR

Salagianni, Maria

17563 Athens, GR

Biomedical Research Foundation of the Academy of Athens

Soranou Efesiou 4, 115 27 Athens, GR

Represchentant

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventur

Andreakos, Evangelos

15451 Athens, GR

Salagianni, Maria

17563 Athens, GR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.